Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Cancer
|
June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14
Allan Lipton, Judy-Anne W Chapman, Laurence Demers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2008
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer
Allan Lipton, Kim Leitzel, Hilary A Chaudri-Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
Allan Lipton, S M Ali, K Leitzel, et al.
JAMA Oncology
|
January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial
Gabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.
Cells
|
March 6, 2021
Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
Bijesh George, P Mukundan Pillai, Aswathy Mary Paul, et al.
Cancer
|
September 24, 2010
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
William K Oh, Roberto Vargas, Susanna Jacobus, et al.
Oncotarget
|
September 9, 2017
Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer
Nicholas Willumsen, Cecilie L Bager, Stephanie N Kehlet, et al.
Breast (Edinburgh, Scotland)
|
January 14, 2024
Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers
Luis Costa, Rakesh Kumar, Cynthia Villarreal-Garza, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Cancer
|
June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14
Allan Lipton, Judy-Anne W Chapman, Laurence Demers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2008
Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer
Allan Lipton, Kim Leitzel, Hilary A Chaudri-Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
Allan Lipton, S M Ali, K Leitzel, et al.
JAMA Oncology
|
January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial
Gabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.
Cells
|
March 6, 2021
Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
Bijesh George, P Mukundan Pillai, Aswathy Mary Paul, et al.
Cancer
|
September 24, 2010
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
William K Oh, Roberto Vargas, Susanna Jacobus, et al.
Oncotarget
|
September 9, 2017
Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer
Nicholas Willumsen, Cecilie L Bager, Stephanie N Kehlet, et al.
Breast (Edinburgh, Scotland)
|
January 14, 2024
Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers
Luis Costa, Rakesh Kumar, Cynthia Villarreal-Garza, et al.
Page
of 15